News and features
Read the latest news and features about our world-leading research, discoveries, fundraising and philanthropy. If you want to keep updated on our news, you can follow us on social media or sign up for our Search newsletter.
If you’re a journalist and want to find out more, you can contact our media relations team.
ICR and The Royal Marsden form part of new radiotherapy research network after receiving major new funding
A new radiotherapy network will unite seven centres across the UK to pioneer the use of the latest technologies, creating a global hub for radiotherapy research.
ICR celebrates major donation from CRIS Cancer Foundation at exclusive supporter event
At our recent Discovery Club event, members thanked CRIS Cancer Foundation for their donation of £1.4 million to support immunotherapy research at the ICR.
How ICR researchers are leading the way in breast cancer research
In Breast Cancer Awareness Month, Rose Wu looks at some of the recent research breakthroughs by breast cancer researchers at the ICR
Drug blocking blood vessel growth could treat rare sarcomas
An experimental targeted drug could treat a rare type of cancer usually affecting the limbs, a clinical trial led by The Institute of Cancer Research has shown.
ICR researchers working with Imperial College London to investigate medical cannabis for cancer and acute pain
Imperial College London researchers are trialling cannabis-based medicinal products for the treatment of cancer and acute pain. The researchers are collaborating with medical cannabis company EMMAC Life Sciences and The Institute of Cancer Research, London, to better understand the effectiveness of the products.
Imaging tumour stiffness could help enhance treatment for breast and pancreatic cancer
Using a non-invasive imaging technique that measures the stiffness of tissues gives crucial new information about cancer architecture and could aid the delivery of treatment to the most challenging tumours, new research shows.
New Athena SWAN Silver Award recognises ICR’s work on diversity and access to opportunities
The ICR is celebrating the work of all our staff and students in creating an open, diverse and fully inclusive environment, with the award of an Athena SWAN Charter Silver Award for 2019-23.
New evolution-busting drug overcomes resistance in aggressive breast cancers
A new type of drug that blocks one of cancer’s key evolutionary escape routes from chemotherapy could be used to treat aggressive breast cancers, a new study has shown.
ICR forms collaboration with AI drug discovery company to develop new possible treatments in rare childhood cancer DIPG
Scientists at The Institute of Cancer Research are working with Healx, a biotech company specialising in artificial intelligence (AI) to discover new possible ways of treating diffuse intrinsic pontine glioma (DIPG), an essentially untreatable brain cancer in children.
Gut bacteria ‘fingerprint’ predicts radiotherapy side effects
Taking a ‘fingerprint’ of the mix of bacteria in the gut can indicate how susceptible individual cancer patients are to gut damage as a result of radiotherapy for prostate and gynaecological cancers, a new study shows.
ESMO 2019: Breast and ovarian cancer drug outperforms targeted hormone therapy in some men with advanced prostate cancer
A drug used for breast and ovarian cancer is more effective than modern targeted hormone treatments at slowing progression and improving survival in some men with advanced prostate cancer, phase III clinical trial findings reveal.
ESMO 2019: Modern chemotherapy drug better than second targeted hormone therapy against resistant prostate cancer
A modern chemotherapy drug is more effective for men with advanced prostate cancer than a second targeted hormone therapy in patients who have stopped responding to treatment, a major clinical trial shows.
